NexgenRx Inc. Stock

NXG

CA65337X1042

Investment Management & Fund Operators

Market Closed - Toronto S.E. Other stock markets 13:08:58 2026-08-07 EDT			5-day change	1st Jan Change
0.6000 ^CAD	0.00%		-7.69%	+50.00%

05-22	Earnings Flash (NXG.V) NexgenRx Reported Q1 Total Revs $5.0M, Up 11.6% YoY; Net Income and EBITDA Improved	MT
05-21	NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

NexgenRx Inc. is a Canada-based independent full-service third-party administrator and technology solutions provider. The Company administers, adjudicates and pays drug, dental and other extended healthcare claims for the beneficiaries of health benefit plans underwritten by its customers, using proprietary computer software and also providing ancillary services. It offers plan sponsors, providers and patient support program/drug manufacturers a full suite of software-as-a-service solutions. The Companyâ€™s products include NexSys, NexAdmin, and NexPSPAssist. The NexSys is a fully integrated rules based adjudication platform for secure real-time processing of drug, dental and extended health benefit claims. Its NexAdmin product enables sponsors to take complete control of benefit plan administration. The NexPSPAssist service helps patient support programs (PSP) to optimize their deliverables to their manufacturer clients.

Employees

Sector

Investment Management & Fund Operators

More about the company

Quotes

Date	Price	Change	Volume
26-08-07	$0.6000	0.00%	1,507
26-08-05	$0.6000	-7.69%	21,810

Delayed Quote Toronto S.E.

More quotes

Income Statement and Estimates

More financial data

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	42.67M 30.62M 26.48M 24.73M 22.69M 2.91B 43.35M 290M 114M 1.46B 115M 112M 4.83B	P/E 2024	55x	P/E 2025	28.6x
Enterprise Value	38.26M 27.45M 23.74M 22.17M 20.34M 2.61B 38.87M 260M 102M 1.31B 103M 101M 4.33B	EV / Sales 2024	1.12x	EV / Sales 2025	1.34x
Free-Float	63.01%	Yield 2024	3.64%	Yield 2025	3.75%

05-22	Earnings Flash (NXG.V) NexgenRx Reported Q1 Total Revs $5.0M, Up 11.6% YoY; Net Income and EBITDA Improved	MT
05-21	NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-19	NexgenRx Inc. announces Semi-Annual dividend, payable on April 28, 2026	CI
03-31	NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12-10	NexgenRx Inc. announces Semi-Annual dividend, payable on December 19, 2025	CI
11-21	NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-21	NexgenRx Q3 Revenue Rises 13%, Net Income and EBITDA Improve	MT
11-20	Earnings Flash (NXG.V) NexgenRx Reported Q3 Revenue $4.6M	MT
25-08-18	NexgenRx Inc. announces Semi-Annual dividend, payable on August 29, 2025	CI
25-08-12	NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-15	NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-17	Nexgenrx Inc. Declares Dividend on Common Shares, Payable on or before April 30, 2025	CI
24-11-25	Nexgenrx Inc. Declares Dividend on Common Shares, Payable on or Before December 20, 2024	CI

1 week	-7.69%
Current month	-7.69%
1 month	+25.00%
3 months	+62.16%
6 months	+55.84%
Current year	+50.00%

1 week	0.55	0.61
1 month	0.48	0.75
Current year	0.29	0.75
1 year	0.29	0.75
3 years	0.18	0.75
5 years	0.18	0.75
10 years	0.14	0.75

Manager	Title	Age	Since
Ronald Loucks CEO	Chief Executive Officer	-	2003-03-12
Phoebe Lee DFI	Director of Finance/CFO	-	-
Kelly Elher DFI	Director of Finance/CFO	63	2016-12-04

NexgenRx Inc. Stock

Stocks

NXG

CA65337X1042

Investment Management & Fund Operators

Valuation: NexgenRx Inc.

Chart: NexgenRx Inc.

Latest news : NexgenRx Inc.

Quotes and Performance

Course Extremes

Managers and Directors: NexgenRx Inc.

Latest insider transactions

Other Investment Management & Fund Operators

Financials

Company Profile

Quotes

Income Statement and Estimates

Director	Title	Age	Since
Ronald Loucks BRD	Director/Board Member	-	2003-03-12
Thomas Corcoran CHM	Chairman	-	2006-03-06
Charles Burns BRD	Director/Board Member	-	2017-06-15

Date	Insider	Type	Main position	Quantity	% Market Cap.
7/24/26	Linda Brennan	Buy	Director	10,000	0.0141%
10/1/24	Paul Everett Crossett	Buy		14,500	0.0204%
9/17/24	Paul Everett Crossett	Buy		20,000	0.0281%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NEXGENRX INC.	0.00%	-7.69%	+64.38%	+100.00%	30.62M
BLACKROCK, INC.	+0.63%	+4.22%	+2.12%	+59.48%	176B
UBS GROUP AG	+0.95%	+2.14%	+38.06%	+124.37%	165B
BANK OF NEW YORK MELLON CORPORATION (THE)	-0.76%	+0.82%	+54.20%	+240.19%	107B
BROOKFIELD CORPORATION	-0.29%	+3.22%	+3.30%	+108.71%	101B
BROOKFIELD ASSET MANAGEMENT LTD.	-1.69%	+7.93%	-12.64%	+66.23%	83.85B
STATE STREET CORPORATION	-0.13%	+0.28%	+68.17%	+149.91%	50.73B
AMERIPRISE FINANCIAL, INC.	-1.40%	+1.12%	+10.74%	+57.92%	48.76B
3I GROUP PLC	-0.14%	+0.10%	-29.02%	+48.90%	38.77B
NORTHERN TRUST CORPORATION	+0.74%	+1.82%	+48.72%	+129.44%	33.94B
Average	-0.21%	+2.07%	+24.80%	+108.51%	80.45B
Weighted average by Cap.	-0.05%	+2.83%	+20.17%	+111.71%

	2024	2025
Net sales	16.48M 11.82M 10.22M 9.55M 8.76M 1.13B 16.74M 112M 43.97M 564M 44.39M 43.42M 1.86B	17.93M 12.87M 11.13M 10.39M 9.53M 1.22B 18.22M 122M 47.86M 614M 48.32M 47.26M 2.03B
Net income	615K 441K 381K 356K 327K 41.97M 624K 4.18M 1.64M 21.03M 1.66M 1.62M 69.54M	1.29M 925K 800K 747K 686K 88.07M 1.31M 8.77M 3.44M 44.14M 3.47M 3.4M 146M
Net Debt	-1.17M -841K -727K -679K -623K -80.02M -1.19M -7.97M -3.13M -40.11M -3.16M -3.09M -133M	-4.41M -3.16M -2.74M -2.56M -2.35M -301M -4.48M -29.99M -11.77M -151M -11.88M -11.62M -499M